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Concluding Remarks 
P. C. SCRIBA 
The title of this symposium "Endemic and Sporadic Goi t re" suggests, that both 
entities may be easily discerned. In fact, this conference has shown the contrary. 
There exists a continous spectrum ranging from countries with severe iodine defi-
ciency, endemic goitre and sometimes even cretinism to countries with very mild 
endemia, some of them realized only recently, there is still existing some iodine de-
ficiency within their borders as Belgium and Denmark. In Europe, only the Scandi-
navian countries are obviously free from any iodine deficiency. 
Both entities, endemic and sporadic goitre, are heterogeneous both in pathogene-
sis and in appearence as discussed with a long list of mechanisms effective in both 
conditions by G. HENNEMANN: cigarette smoking drew attention to its role as a re-
discovered goitrogen and the role of immunomechan i sms leading to non-toxic goi-
tre (thyroid growth stimulating immunoglobulins) was amply discussed. TGI ' s pos-
sible contribution to sporadic goitre prolongs the list of goitrogens. 
A plea for a better epidemiology leading to new data on the incidence of goitre 
and on the urinary iodine excretion was put forward. An improved iodine prophy-
laxis performed with more consequence would hopefully result in the final 
disappearance of any endemic goitre leaving us with the truely sporadic goitre. The 
future incidence of the latter disease and its heterogeneity will have to be defined. 
The diagnosis of non-toxic goitre in the individual patient is usually achieved by 
excluding all other possible thyroid diseases. This problem was only briefly touch-
ed. However, it has become very clear, that the diagnostic definition of the non-to-
xic goitre subgroups needs improvement, when therapeutic studies are being plan-
ed. Some of the therapeutic reports clearly lacked a definition of the degree of 
iodine deficiency and statements about "goitre age", consistence, volume, patient 
age groups and criteria for monitoring of side effects, therapeutic success and fol-
low-up. In this sense, therapeutic studies are obviously difficult to perform. 
During this conference, volumetry by means of ultrasonography was well accept-
ed as a technique, which improves the control of therapeutic studies. It may be 
noteworthy, that one has to go as far as Stockholm in order to observe normal thy-
roid volumes both in school children and in adults! 
Thyroid hormones, thyroxine, tri iodthyronine and the combinat ion of both, 
were discussed as medications for non-toxic goitre; in addit ion and perhaps as a 
surprise to some of us, there may be something like a renaissance of iodide for this 
treatment. However, it is probably fair to state, that some of the studies reported 
are still in the experimental phase. The regimen providing the m a x i m u m of an anti-
goitrogenic effect and the minimum of thyrotoxic side effects is still debated. In ad-
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dition, follow-up studies will have to show the most effective means in order to pre-
vent the occurence of goitre after medical treatment. 
The results discussed apply largely to iodine deficiency goitre; the treatment of 
this disease is still necessary but it is hoped, that iodine prophylaxis will make it as 
superfluous as in Finland (A. LAMBERG). - There is a severe lack of information 
about the treatment of the subgroups of sporadic goitre in the presence of sufficient 
iodine intake, however. 
Obviously, there remains a lot of important work for all of us to do. 
Finally, it is my privilege and also my pleasure to thank the scientific organizers 
of this conference, Drs. R E I N W E I N and BEYSEL, and their helpers. Contributors and 
participants in this conference have made it a lively and interesting event. The 
most generous sponsor has made this conference in the beautiful city of Budapest a 
very pleasant experience which will last in our memory. Thank you all. 
